Cano Health, Inc.
NYSE:CANO
2.3 (USD) • At close February 2, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 2,738.916 | 1,609.369 | 831.576 | 361.384 |
| Cost of Revenue
| 2,317.223 | 1,410.4 | 666.345 | 284.672 |
| Gross Profit
| 421.693 | 198.969 | 165.231 | 76.712 |
| Gross Profit Ratio
| 0.154 | 0.124 | 0.199 | 0.212 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 394.243 | 252.133 | 103.962 | 59.148 |
| Selling & Marketing Expenses
| 28.2 | 19.4 | 8.7 | 4.5 |
| SG&A
| 422.443 | 252.133 | 103.962 | 59.148 |
| Other Expenses
| 90.64 | 49.441 | 18.499 | 6.822 |
| Operating Expenses
| 513.083 | 301.574 | 122.461 | 65.97 |
| Operating Income
| -89.67 | -102.605 | 42.64 | 10.811 |
| Operating Income Ratio
| -0.033 | -0.064 | 0.051 | 0.03 |
| Total Other Income Expenses Net
| -336.562 | -14.118 | -113.053 | -30.591 |
| Income Before Tax
| -426.232 | -116.723 | -70.413 | -19.78 |
| Income Before Tax Ratio
| -0.156 | -0.073 | -0.085 | -0.055 |
| Income Tax Expense
| 2.157 | 0.014 | 0.651 | 9.913 |
| Net Income
| -428.389 | -116.737 | -71.064 | -29.693 |
| Net Income Ratio
| -0.156 | -0.073 | -0.085 | -0.082 |
| EPS
| -195.46 | -24.54 | -42.75 | -17.86 |
| EPS Diluted
| -195.46 | -24.54 | -42.75 | -17.86 |
| EBITDA
| 0.97 | -53.208 | 61.139 | 17.633 |
| EBITDA Ratio
| 0 | -0.033 | 0.074 | 0.049 |